Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund (ETB) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund (ETB) over the past year, gaining 11.2% versus a gain of 2.7%. Over five years, ETB leads with a -5.6% price change compared with -15.0% for HQL. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 5.5x for Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund).
abrdn Life Sciences Investors offers the higher dividend yield (10.96% vs 8.24%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETB | HQL |
|---|---|---|
| Share price | $15.46 | $17.43 |
| Market cap | $454.13M | — |
| 1-day change | -0.13% | -0.74% |
| YTD return | +1.38% | +4.65% |
| 1-year return | +2.72% | +11.21% |
| 5-year return | -5.61% | -15.00% |
| P/E ratio (TTM) | 5.46 | 2.63 |
| EPS (TTM) | $2.83 | $6.64 |
| Dividend yield | 8.24% | 10.96% |
| Annual dividend | $1.27 | $1.91 |
| 52-week high | $15.82 | $22.67 |
| 52-week low | $13.86 | $15.66 |
| Distance from 52-week high | -2.28% | -23.11% |
| Average volume | 48.63K | 147.31K |
| Shares outstanding | 29.37M | — |
| Sector | Finance | Finance |
| Industry | Investment Bankers/Brokers/Service | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund trades at a higher earnings multiple (5.5x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.96% vs 8.24%).
About Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund
ETB stock →Eaton Vance Tax-Managed Buy-Write Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It is co-managed by Parametric Portfolio Associates LLC.
Finance · Investment Bankers/Brokers/Service
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
ETB vs HQL FAQ
Which stock has performed better over the past year, ETB or HQL?
HQL returned +11.21% over the past 12 months, compared with +2.72% for ETB (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ETB or HQL?
HQL has the lower trailing P/E at 2.6, versus 5.5 for ETB. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 10.96%, compared with 8.24% for Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund.
Are Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund and abrdn Life Sciences Investors in the same industry?
Both are in the Finance sector, but in different industries: Investment Bankers/Brokers/Service for Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund and Investment Managers for abrdn Life Sciences Investors.